- Tyler Cowen on the price of Ozempic.
- Problems with the OMB’s social welfare function.
- Link between alcohol and cancer.
- Disparities in the rural-urban life expectancy.
- Why will Part D plans “…move drugs that are selected for [MFP] negotiation into a higher cost-sharing tier”?
Disclaimer :
This article is solely for informational purposes, any medical information contained is not a substitute for professional medical advice and readers should not rely on it as such.
If you believe there may be errors or misinformation in this article, we encourage you to contact the webmasters by messaging the provided contact information.
Your feedback is valuable, and we are committed to rectifying any inaccuracies. Please note that the content will be re-evaluated, and corrections will be made as necessary following your submission.